Gurnet Point Capital — Full Portfolio
3 tracked investments · listed companies and verified rows first
BiotechWatertown, US
Edward Mascioli(Executive Officer)Andrew Myers(Director)
BoardMarkus Goebel(Director)Henry Skinner(Director)inVikas Goyal(Director)Raj Parekh(Director)in
Co-investorsAdvent Life SciencesNovartis Venture FundRoche Venture Fund
Naveris develops and commercializes liquid biopsy tests for the early detection and monitoring of HPV-associated cancers, particularly head and neck and anal cancers.
BiotechData & InfrastructureDigital HealthHealthtechMedical DevicesWaltham, US
James McNally(Executive Officer, Director)inPiyush Gupta(Executive Officer, Director)
BoardAnne Stone(Director)Francis Crispino(Director)Philip Grahame Haydon(Director)
Co-investorsTechU Ventures
Tremeau develops non-opioid pain therapies for patient populations with high unmet medical needs.
BiotechHealthtechCambridge, US
Bradford C. Sippy(Executive Officer, Director)Benjamin Enerson(Executive Officer)Mark Corrigan(Executive Officer)in
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.